Citation Impact
Citing Papers
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
The Epidemiology of Transsexualism in Iran
2010
COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses
2020 Standout
Global health burden and needs of transgender populations: a review
2016 Standout
Clinical management of tuberculosis and HIV-1 co-infection
2010
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine
2011
Management of Cryptococcal Meningitis in Sub-Saharan Africa
2010
Compassionate use of amphotericin B lipid complex (Abelcet) in life-threatening fungal infections: report of 30 courses
1998
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care
1998
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385
2006
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection
1997
HIV/AIDS: Interactions between Natural Health Products and Antiretroviral Drugs: Pharmacokinetic and Pharmacodynamic Effects
2006
Amphotericin B Formulations and Drug Targeting
2007
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Invasive Infection Due to Candida krusei in Immunocompromised Patients Not Treated with Fluconazole
1995
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid‐organ transplant recipients with invasive fungal infections
2000
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Copper-Mediated Coupling Reactions and Their Applications in Natural Products and Designed Biomolecules Synthesis
2008 Standout
Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review
2020 Standout
Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?
2015
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Worldwide Variation in Human Drug-Metabolism Enzyme GenesCYP2B6andUGT2B7: Implications for HIV/AIDS Treatment
2012
Current and Emerging Azole Antifungal Agents
1999 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The Immune Response in Tuberculosis
2013 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Rational Design of Doravirine: From Bench to Patients
2019
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Coronavirus Infections—More Than Just the Common Cold
2020 Standout
Works of SH Khoo being referenced
The intracellular pharmacology of antiretroviral protease inhibitors
2004
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy
2010
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV
2006
Administering amphotericin B—a practical approach
1994
Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans
2009
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
2011
The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC
2009
Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study
2015
T12-O-04 Strategies of discussing AIDS and their relation to anxiety about AIDS among sexual minorities in Iran
2008